Global Med Technologies(R), Inc. Licenses and Deploys its EdgeLab Laboratory Software...

* Reuters is not responsible for the content in this press release.

Wed May 27, 2009 1:18pm EDT

Global Med Technologies(R), Inc. Licenses and Deploys its EdgeLab Laboratory
Software at Eugene Andre Hospital in Lyon, France

Global Med's Inlog, S.A., Subsidiary Continues its Strong Sales Presence in
the European Market

DENVER, May 27 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.
("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international
e-Health, medical information technology company, today announced that its
Inlog subsidiary has licensed and deployed its EdgeLab Laboratory Information
Management Software (Marketed as "Labo Serveur" in France) to the Eugene Andre
Hospital near Lyon, France.  Terms of the agreement were not disclosed.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

Since EdgeLab was introduced into the hospital market in 1999 as "Labo
Serveur", it has become a leading laboratory information management system in
Europe with more than 150 licensed laboratories. EdgeLab is connected with
more than 1,000 analyzers and interchanges data with all major hospital
healthcare software applications.  It has a vibrant, easy-to-use Windows
graphical interface in addition to a comprehensive range of laboratory
functionality.  EdgeLab can be easily configured to meet the business needs of
large, diverse, multi-site hospital laboratories, as well as small,
single-site hospitals.

Mr. Magnin, Head of Laboratory Service of Eugene Andre Hospital, explained,
"In April, 2008 after the announcement that Agfa was discontinuing the
maintenance of our HPX software, we decided to replace our product and
contacted three companies whose computer solutions seemed to be suitable for
our laboratory.  The IT Department of our hospital took part in the decision. 
This allowed us to have two viewpoints on a new laboratory product:  a
functional viewpoint for the biologists and an equipment and architectural
viewpoint for the IT technicians.  For both parties involved in the decision,
it was determined that EdgeLab answered our needs the best.  The user feedback
was positive both in terms of functionality and post sales support.  We were
provided with great support throughout the process and for us this was a sign
of future success.  The flexibility of the EdgeBlood configuration appealed to
us.  We added additional functionality to what our legacy software offered,
including a document manager, a results server in the ward, and connection to
the Biomnis Laboratory. The implementation was completed in less than 3
months, and this included the absence of the head biologist for 15 days during
the project."

At Eugene Andre Hospital, EdgeLab is directly connected to six laboratory
analyzers, the hospital management system and several other external systems,
including Inlog's EdgeBlood blood center information management system at the
French Blood Establishment (EFS).  EFS uses EdgeBlood to recruit, collect,
process and label 100 percent of the blood drawn in France. 

Will Willman, Global Med's Sr. Vice President of Sales and Marketing
EU/ME/Asia, commented, "We are excited to have been chosen to assist Clinique
Mutualiste's Eugene Andre Hospital with their laboratory information
management system needs.  EdgeLab has become a leading laboratory information
system in Europe because it has kept current with the needs of the marketplace
by providing hospital laboratories with the advanced features and functions
they require.  We are looking forward to supporting Eugene Andre with quality
products and services as they continue to provide excellent, advanced
healthcare to patients in the greater Lyon area."
 
About the "Clinique Mutualiste Eugene Andre Hospital"
Founded in 1935, Clinique Mutualiste Eugene Andre Hospital was initially
formed to serve subscribers to not-for-profit healthcare insurance plans.  In
1976, it opened its doors to the general public and, like most French
hospitals, is now primarily funded by the French Government.

About Global Med Technologies(R), Inc.   
Global Med Technologies, Inc. is an international healthcare information
technology company which develops regulated and non-regulated products and
services for the healthcare industry.  As a leading provider of blood and
laboratory systems and services, Global Med's products are deployed in 20
countries and serve over 2,100 transfusion centers, blood banks and laboratory
sites.  

Global Med's domestic companies are Wyndgate Technologies(R), a leader in
software products and services for donor centers and hospital transfusion
services; eDonor(R), which offers web-based donor relationship management
systems; and PeopleMed(TM), Inc., which implements cost-effective software
validation, consulting and compliance solutions to hospitals and donor
centers.  

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor
center and transfusion management systems as well as cellular therapy
software, laboratory information systems and quality assurance medical
software systems internationally.  

For more information about Global Med's products and services, please call
800-996-3428 or visit www.globalmedtech.com. 

This news release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions.  These statements are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of
1995.  Forward-looking statements inherently involve risks and uncertainties
that could cause actual results to differ materially from the forward-looking
statements.  By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or changes
after the date of this news release.



SOURCE  Global Med Technologies, Inc.

Michael I. Ruxin, M.D., +1-303-238-2000, mick@globalmedtech.com, or Investors,
Karen Davis, CFO, +1-916-404-8495, davisk@globalmedtech.com, both of Global
Med Technologies, Inc.
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.